These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 311349)

  • 1. Immunological studies in patients with alopecia areata.
    Herzer P; Czarnetzki BM; Holzmann H; Lemmel EM
    Int Arch Allergy Appl Immunol; 1979; 58(2):212-8. PubMed ID: 311349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor cell number and function in alopecia areata.
    Hordinsky MK; Hallgren H; Nelson D; Filipovich AH
    Arch Dermatol; 1984 Feb; 120(2):188-94. PubMed ID: 6230058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological profiles in alopecia areata.
    Galbraith GM; Thiers BH; Vasily DB; Fudenberg HH
    Br J Dermatol; 1984 Feb; 110(2):163-70. PubMed ID: 6607739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological study of alopecia areata].
    Wüthrich B; Grob PJ; Zisiadis S
    Hautarzt; 1980 Sep; 31(9):495-501. PubMed ID: 6969719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T and B lymphocytes in DNCB-treated alopecia areata (author's transl)].
    Cisło M; Wasik F; Bliźanowska A
    Dermatol Monatsschr; 1981 Jun; 167(6):356-61. PubMed ID: 6974106
    [No Abstract]   [Full Text] [Related]  

  • 6. [DNCB therapy for alopecia areata (author's transl)].
    Zisiadis S; Wüthrich B; Schnyder UW
    Dermatologica; 1980; 161(6):365-71. PubMed ID: 7215615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immune competence of patients with Crohn's disease (author's transl)].
    Tönnesmann E; Bürkle PA; Schäfer B; Federlin K
    Klin Wochenschr; 1979 Oct; 57(20):1097-107. PubMed ID: 513603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of alopecia areata to DNCB: influence of auto-antibodies and route of sensitization.
    Friedmann PS
    Br J Dermatol; 1981 Sep; 105(3):285-9. PubMed ID: 7272208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of alopecia areata with dinitrochlorobenzene.
    Daman LA; Rosenberg EW; Drake L
    Arch Dermatol; 1978 Jul; 114(7):1036-8. PubMed ID: 308348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between inducer/suppressor ratios, generation of concanavalin A-activated suppressor cells, and mitogen-stimulated proliferation of peripheral blood lymphocytes in patients with alopecia areata and normal controls.
    Filipovich AH; Hordinsky-Kramarczuk M; Nelson D; Hallgren H
    Clin Immunol Immunopathol; 1982 Oct; 25(1):21-31. PubMed ID: 6217938
    [No Abstract]   [Full Text] [Related]  

  • 11. Dinitrochlorobenzene therapy for alopecia areata.
    Happle R; Cebulla K; Echternacht-Happle K
    Arch Dermatol; 1978 Nov; 114(11):1629-31. PubMed ID: 152611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of DNCB therapy on the T-cell subsets of the cases with alopecia areata.
    Gülekon A; Gürer MA; Bozkurt M; Keskin N
    Int J Dermatol; 1989 Dec; 28(10):684-5. PubMed ID: 2592136
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased lymphocyte reactivity and auto-immunity in alopecia areata.
    Friedmann PS
    Br J Dermatol; 1981 Aug; 105(2):145-51. PubMed ID: 6974565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis).
    Ranki A; Kianto U; Kanerva L; Tolvanen E; Johansson E
    J Invest Dermatol; 1984 Jul; 83(1):7-11. PubMed ID: 6376642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
    Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disappointing results with dinitrochlorobenzene in alopecia areata (author's transl)].
    Lindemayr H
    Wien Klin Wochenschr; 1981 Feb; 93(4):131-4. PubMed ID: 7281686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution to the DNCB therapy of alopecia areata].
    Gutschmidt E
    Z Hautkr; 1979 May; 54(10):430-5. PubMed ID: 473839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dinitrochlorobenzene treatment of alopecia areata.
    de Prost Y; Paquez F; Touraine R
    Arch Dermatol; 1982 Aug; 118(8):542-5. PubMed ID: 7103522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subpopulations and their functions in vitro. A study in patients with alopecia areata and alopecia universalis.
    Gu SQ; Ros AM; von Stedingk LV; Thyresson N; Wasserman J
    Int Arch Allergy Appl Immunol; 1981; 66(2):208-17. PubMed ID: 6974701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood lymphocyte subpopulations and antibody dependent, cell-mediated cytotoxicity (ADCC) in alopecia areata and universalis.
    Gu SQ; Ros AM; Thyresson N; Wasserman J
    Acta Derm Venereol; 1981; 61(2):125-9. PubMed ID: 6165187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.